Events Calendar

Mon
Tue
Wed
Thu
Fri
Sat
Sun
M
T
W
T
F
S
S
29
30
1
2
3
4
5
7
8
10
11
12
13
14
15
16
17
18
20
22
23
24
25
26
27
28
29
30
31
1
C.D. Howe Institute Roundtable Luncheon
2014-04-28    
12:00 pm - 1:30 pm
Navigating the Healthcare System: The Patient’s Perspective Please join us for this Roundtable Luncheon at the C.D. Howe Institute with Richard Alvarez, Chief Executive Officer, [...]
DoD / VA EHR and HIT Summit
DSI announces the 6th iteration of our DoD/VA iEHR & HIE Summit, now titled “DoD/VA EHR & HIT Summit”. This slight change in title is to help [...]
Electronic Medical Records: A Conversation
2014-05-09    
1:00 pm - 3:30 pm
WID, the Holtz Center for Science & Technology Studies and the UW–Madison Office of University Relations are offering a free public dialogue exploring electronic medical records (EMRs), a rapidly disseminating technology [...]
The National Conference on Managing Electronic Records (MER) - 2014
2014-05-19    
All Day
" OUTSTANDING QUALITY – Every year, for over 10 years, 98% of the MER’s attendees said they would recommend the MER! RENOWNED SPEAKERS – delivering timely, accurate information as well as an abundance of practical ideas. 27 SESSIONS AND 11 TOPIC-FOCUSED THEMES – addressing your organization’s needs. FULL RANGE OF TOPICS – with sessions focusing on “getting started”, “how to”, and “cutting-edge”, to “thought leadership”. INCISIVE CASE STUDIES – from those responsible for significant implementations and integrations, learn how they overcame problems and achieved success. GREAT NETWORKING – by interacting with peer professionals, renowned authorities, and leading solution providers, you can fast-track solving your organization’s problems. 22 PREMIER EXHIBITORS – in productive 1:1 private meetings, learn how the MER 2014 exhibitors are able to address your organization’s problems. "
Chicago 2014 National Conference for Medical Office Professionals
2014-05-21    
12:00 am
3 Full Days of Training Focused on Optimizing Medical Office Staff Productivity, Profitability and Compliance at the Sheraton Chicago Hotel & Towers Featuring Keynote Presentation [...]
Events on 2014-04-28
Events on 2014-05-06
DoD / VA EHR and HIT Summit
6 May 14
Alexandria
Events on 2014-05-09
Latest News

Factors Predicting Poor Locoregional Control in Tongue Cancer

In patients with pT1-2N0 oral tongue squamous cell carcinoma undergoing partial glossectomy and elective neck dissection, inferior locoregional control (LRC) was associated with depth of invasion, lymphovascular space invasion, and positive glossectomy specimen margins. These retrospective findings, presented at the 2024 ASTRO Multidisciplinary Head and Neck Cancers Symposium, remained significant even in cases with final negative tumor bed margins.At a median follow-up of 45.6 months, the all-comer patient population exhibited 3-year locoregional control (LRC) and overall survival (OS) rates of 88.0% and 92.5%, respectively. Among patients with pT1 disease, these rates were 92.0% and 95.2%, while in those with pT2 disease, the rates were 85.0% and 90.5%.

However, during the multivariate analysis, individuals with positive glossectomy margins exhibited poorer locoregional control (HR, 6.66; 95% CI, 1.60-27.78; P = .009). Lymphovascular space invasion (HR, 6.90; 95% CI, 1.42-33.65; P = .02) and depth of invasion (HR, 1.31; 95% CI, 1.06-1.63; P = .01) were also correlated with diminished locoregional control.

The lead study author, Michael Modzelewski, MD, along with the co-investigators, stated in a poster presented at the meeting, “Patients with these risk factors may be considered for adjuvant radiotherapy to optimize disease control.”

Individuals with early-stage tongue squamous cell carcinoma typically do not undergo adjuvant radiation due to their low recurrence risk. After surgery, the status of the primary glossectomy specimen margin has been observed to have a stronger correlation with local recurrence than the status of additional tumor bed margins, as stated by the authors.

The investigators aimed to identify the pathological factors associated with locoregional recurrence in patients with early-stage tongue squamous cell carcinoma who underwent surgery alone. Additionally, they explored the impact of a positive glossectomy specimen margin on disease control concerning final negative tumor bed margins.

The research included 110 patients diagnosed with pT1-2N0 oral tongue squamous cancer, adhering to the American Joint Committee on Cancer (AJCC) 8th edition criteria. These individuals underwent partial glossectomy and elective dissection from 2015 to 2021, excluding adjuvant radiation. Pathology reports were examined for factors such as tumor size, depth of invasion, glossectomy specimen margin, final tumor bed margin status, and perineural or lymphovascular space invasion. Individuals with positive final margins or a history of head and neck radiation were excluded.

The Kaplan-Meier method was employed to estimate locoregional control (LRC) and overall survival (OS), with a Cox proportional hazards model identifying prognostic factors for LRC in multivariate analysis.

Concerning baseline characteristics, the median age was 52 years, with the majority being male (54.5%) and having pT2 stage disease (58.2%). There were 33 lymph nodes dissected on average, and the median tumor size measured 16 mm, with a depth of invasion reaching 5 mm.

The majority of patients did not exhibit perineural invasion (84.7%), while 3.6% had lymphovascular space invasion. Positive glossectomy specimen margins were observed in 8.2% of cases.

Further findings revealed that among patients with positive glossectomy specimen margins and those without, the 3-year locoregional control (LRC) rates were 66.7% and 89.5%, respectively. Similarly, the rates were 0.0% for individuals with lymphovascular space invasion and 89.4% for those without. Among the 8 patients experiencing regional failure, 5 had recurrence in the ipsilateral neck alone (62.5%), 2 in the bilateral neck (25.0%), and 1 with isolated contralateral neck recurrence (12.5%).